Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation

Abstract

Perturbation of addition of second heart field (SHF) cardiac progenitor cells to the poles of the heart tube results in congenital heart defects (CHD). The transcriptional programs and upstream regulatory events operating in different subpopulations of the SHF remain unclear. Here, we profile the transcriptome and chromatin accessibility of anterior and posterior SHF sub-populations at genome-wide levels and demonstrate that Hoxb1 negatively regulates differentiation in the posterior SHF. Spatial mis-expression of Hoxb1 in the anterior SHF results in hypoplastic right ventricle. Activation of Hoxb1 in embryonic stem cells arrests cardiac differentiation, whereas Hoxb1-deficient mouse embryos display premature cardiac differentiation. Moreover, ectopic differentiation in the posterior SHF of embryos lacking both Hoxb1 and its paralog Hoxa1 results in atrioventricular septal defects. Our results show that Hoxb1 plays a key role in patterning cardiac progenitor cells that contribute to both cardiac poles and provide new insights into the pathogenesis of CHD.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2 and 3.

Article and author information

Author details

  1. Sonia Stefanovic

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Brigitte Laforest

    Department of Pediatrics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6919-8922
  3. Jean-Pierre Desvignes

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Fabienne Lescroart

    INSERM, MMG, U1251, Aix-Marseille Université, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4942-7921
  5. Laurent Argiro

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Corinne Maurel-Zaffran

    IBDM, CNRS-AMU, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  7. David Salgado

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Elise Plaindoux

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Christopher De Bono

    IBDM, CNRS UMR7288, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Kristijan Pazur

    Paul Langerhans Institute Dresden of Helmholtz Centre Munich, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Magali Théveniau-Ruissy

    INSERM U1251 Marseille Medical Genetics, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7346-7096
  12. Christophe Béroud

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Michel Puceat

    INSERM U1251 Marseille Medical Genetics, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9055-7563
  14. Anthony Gavalas

    Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Robert G Kelly

    CNRS UMR 7288, Aix-Marseille Université, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Stephane Zaffran

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    For correspondence
    stephane.zaffran@univ-amu.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0811-418X

Funding

Agence Nationale de la Recherche (ANR-13-BSV2-0003)

  • Michel Puceat
  • Robert G Kelly
  • Stephane Zaffran

Agence Nationale de la Recherche (ANR-18-CE13-0011)

  • Robert G Kelly
  • Stephane Zaffran

Fondation Lefoulon Delalande

  • Sonia Stefanovic
  • Fabienne Lescroart

Association Française contre les Myopathies (MNH-Decrypt)

  • Stephane Zaffran

Fondation pour la Recherche Médicale

  • Brigitte Laforest

Fondation pour la Recherche Médicale (DEQ20150331717)

  • Robert G Kelly

European Commission (H2020-MSCA-IF-2014)

  • Sonia Stefanovic

Fondation Leducq (Research Equipment and Technological Platform Awards)

  • Michel Puceat
  • Robert G Kelly
  • Stephane Zaffran

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Richard P Harvey, Victor Chang Cardiac Research Institute, Australia

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal procedures were carried out under protocols approved by a national appointed ethical committee for animal experimentation (Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche; Authorization N{degree sign}32-08102012).

Version history

  1. Received: January 13, 2020
  2. Accepted: August 16, 2020
  3. Accepted Manuscript published: August 17, 2020 (version 1)
  4. Version of Record published: September 1, 2020 (version 2)

Copyright

© 2020, Stefanovic et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,639
    Page views
  • 354
    Downloads
  • 33
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sonia Stefanovic
  2. Brigitte Laforest
  3. Jean-Pierre Desvignes
  4. Fabienne Lescroart
  5. Laurent Argiro
  6. Corinne Maurel-Zaffran
  7. David Salgado
  8. Elise Plaindoux
  9. Christopher De Bono
  10. Kristijan Pazur
  11. Magali Théveniau-Ruissy
  12. Christophe Béroud
  13. Michel Puceat
  14. Anthony Gavalas
  15. Robert G Kelly
  16. Stephane Zaffran
(2020)
Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation
eLife 9:e55124.
https://doi.org/10.7554/eLife.55124

Share this article

https://doi.org/10.7554/eLife.55124

Further reading

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.

    1. Developmental Biology
    2. Neuroscience
    Smrithi Prem, Bharati Dev ... Emanuel DiCicco-Bloom
    Research Article

    Autism spectrum disorder (ASD) is defined by common behavioral characteristics, raising the possibility of shared pathogenic mechanisms. Yet, vast clinical and etiological heterogeneity suggests personalized phenotypes. Surprisingly, our iPSC studies find that six individuals from two distinct ASD-subtypes, idiopathic and 16p11.2 deletion, have common reductions in neural precursor cell (NPC) neurite outgrowth and migration even though whole genome sequencing demonstrates no genetic overlap between the datasets. To identify signaling differences that may contribute to these developmental defects, an unbiased phospho-(p)-proteome screen was performed. Surprisingly despite the genetic heterogeneity, hundreds of shared p-peptides were identified between autism subtypes including the mTOR pathway. mTOR signaling alterations were confirmed in all NPCs across both ASD-subtypes, and mTOR modulation rescued ASD phenotypes and reproduced autism NPC associated phenotypes in control NPCs. Thus, our studies demonstrate that genetically distinct ASD subtypes have common defects in neurite outgrowth and migration which are driven by the shared pathogenic mechanism of mTOR signaling dysregulation.